Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TYROBP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A gene referenced in 1 knowledge graph relationship. Key connections: encodes DAP12 (protein).
No AI portrait yet
| Gene Symbol | TYROBP |
| Aliases | DAP12 |
| Chromosome | 19q13.12 |
| Protein Type | Adaptor Protein |
| Function | is a transmembrane signaling adaptor protein that plays critical roles in innate immunity and microglial function in the central nervous system. |
| Primary Expression | Microglia, Monocytes, NK cells, Osteoclasts |
| Molecular Weight | 12.1 kDa |
| Amino Acids | 113 aa |
| Pathways | Innate Immunity |
| UniProt ID | Q9Y241 |
| NCBI Gene ID | 7305 |
| Ensembl ID | ENSG00000111653 |
| OMIM | 605712 |
| GeneCards | TYROBP |
| Human Protein Atlas | TYROBP |
| Associated Diseases | Aging, Als, Alzheimer, alzheimer_disease, Alzheimer's disease |
| Known Drugs/Compounds | BERBERINE |
| Interactions | AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AMYLOID-BETA, AND |
| SciDEX Hypotheses | TYROBP (DAP12) Conditional Antagonism for Early-St |
| KG Connections | 396 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
TYROBP["TYROBP"] -->|"interacts"| TREM2["TREM2"]
TYROBP["TYROBP"] -->|"expressed in"| microglia["microglia"]
TYROBP["TYROBP"] -->|"interacts"| Alzheimer["Alzheimer"]
TYROBP["TYROBP"] -->|"interacts"| Ms["Ms"]
TYROBP["TYROBP"] -->|"activates"| Als["Als"]
TYROBP["TYROBP"] -->|"associated"| Alzheimer_1["Alzheimer"]
RANK["RANK"] -->|"activates"| TYROBP["TYROBP"]
GENES["GENES"] -->|"activates"| TYROBP["TYROBP"]
APP["APP"] -->|"associated"| TYROBP["TYROBP"]
CD33["CD33"] -->|"associated"| TYROBP["TYROBP"]
style TYROBP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| ds-db4a006ea647 | provides_data_for | dataset | 1.00 |
| SIRPΒ1 | interacts_with | receptor | 0.95 |
| Late-Onset Alzheimer's Disease | associated_with | disease | 0.95 |
| CR3 | binds | receptor | 0.95 |
| Brain Homeostasis | involved_in | process | 0.90 |
| Signal Transduction | mediates | process | 0.90 |
| Pathogen Phagocytosis | regulates | process | 0.90 |
| SIRP1B | interacts_with | receptor | 0.90 |
| Gene Expression Changes | causes | phenotype | 0.87 |
| tau phosphorylation | regulates | process | 0.85 |
| Disease-Associated Microglia | regulates | phenotype | 0.85 |
| Molecular Interaction Networks | component_of | pathway | 0.85 |
| Alzheimer's Disease pathogenesis | mediates | mechanism | 0.85 |
| C1Q | regulates | protein | 0.85 |
| Alzheimer's Disease | associated_with | disease | 0.85 |
| Immune Cell Infiltration | associated_with | process | 0.80 |
| Learning Behavior | regulates | phenotype | 0.80 |
| Synaptic Function | regulates | process | 0.80 |
| Learning Behavior | involved_in | phenotype | 0.75 |
| Synaptic Function | involved_in | process | 0.75 |
| Als | activates | disease | 0.75 |
| Neurodegenerative Diseases | risk_factor_for | disease | 0.75 |
| microglia | expressed_in | cell_type | 0.72 |
| TREM2 | interacts_with | protein | 0.72 |
| neuroinflammation | activates | disease | 0.70 |
| phagocytic function | modulates | mechanism | 0.70 |
| SYK | phosphorylates | gene | 0.70 |
| SYK | interacts_with | gene | 0.70 |
| DEMENTIA | increases_risk | disease | 0.65 |
| TREM2 | encodes | gene | 0.65 |
| TAU | exacerbates | protein | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Epilepsy | regulates | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Atherosclerosis | associated_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| ALZHEIMER'S DISEASE | increases_risk | disease | 0.65 |
| DEMENTIA | interacts_with | disease | 0.65 |
| UNFOLDED PROTEIN RESPONSE | causes | pathway | 0.65 |
| CANCER | promotes | disease | 0.65 |
| MICROGLIA | promotes | cell_type | 0.65 |
| NEURODEGENERATION | mediates | disease | 0.65 |
| CANCER | activates | disease | 0.65 |
| ALZHEIMER | protects_against | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| NLRP3 | inhibits | gene | 0.65 |
| SYK | regulates | gene | 0.65 |
| STAT3 | regulates | gene | 0.65 |
| STAT3 | promotes | gene | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ds-db4a006ea647 | data_in | dataset | 1.00 |
| TREM2 | interacts_with | entity | 0.90 |
| h-trem2-f3effd21 | targets_gene | hypothesis | 0.90 |
| Immune and Microglia Module | associated_with | pathway | 0.89 |
| GENES | activates | gene | 0.70 |
| MICROGLIA | regulates | cell_type | 0.70 |
| MICROGLIA | inhibits | cell_type | 0.70 |
| MICROGLIA | activates | gene | 0.70 |
| TREM2 | co-expressed in | gene | 0.70 |
| CD163 | activates | gene | 0.70 |
| GRN | activates | gene | 0.65 |
| NEUROINFLAMMATION | regulates | phenotype | 0.65 |
| BERBERINE | regulates | drug | 0.65 |
| BERBERINE | activates | drug | 0.65 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.65 |
| NEUROINFLAMMATION | protects_against | phenotype | 0.65 |
| DAP12 | interacts_with | gene | 0.65 |
| MICROGLIAL ACTIVATION | treats | phenotype | 0.65 |
| MICROGLIA | produces | cell_type | 0.65 |
| ALZHEIMER'S DISEASE | targets | disease | 0.65 |
| TREM2 | associated_with | gene | 0.60 |
| OVERVIEW | interacts_with | gene | 0.60 |
| PSEN1 | associated_with | gene | 0.60 |
| RANK | regulates | entity | 0.60 |
| TMEM119 | associated_with | gene | 0.60 |
| AIF1 | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | interacts_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| CD33 | associated_with | gene | 0.60 |
| COMPLEMENT | associated_with | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | associated_with | gene | 0.60 |
| APOE3 | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| ALZHEIMER | interacts_with | gene | 0.60 |
| APP/PSEN1 | associated_with | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| TAUOPATHY | expressed_in | gene | 0.60 |
| PHAGOCYTOSIS | regulates | entity | 0.60 |
| PHAGOCYTOSIS | associated_with | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| MMP12 | activates | gene | 0.60 |
| CD33 | activates | gene | 0.60 |
| ITGAM | associated_with | gene | 0.60 |
| C1QC | associated_with | gene | 0.60 |
| MICROGLIA | co_discussed | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TYROBP (DAP12) Conditional Antagonism for Early-Stage Neurop | 0.844 | neurodegeneration | TREM2 agonism vs antagonism in DAM micro |
| TREM2 Signaling Bifurcation with Independent TYROBP-Independ | 0.591 | neuroinflammation | Why is TYROBP deficiency neuroprotective |
| SYK-Independent TREM2 Pathways Remain Functional in TYROBP D | 0.548 | neuroinflammation | Why is TYROBP deficiency neuroprotective |
| TYROBP Network Hyperactivation Marks Point of No Return | 0.463 | neurodegeneration | What is the optimal therapeutic window f |
| TYROBP Causal Network Inhibition for Microglial Repolarizati | 0.105 | neurodegeneration | Neuroinflammation Biomarker Panel for Ea |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 0 hypotheses
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.591
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-04 | 5 hypotheses Top: 0.640
neurodegeneration | 2026-04-03 | 45 hypotheses Top: 0.990
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] | Li H, Xie Z, Tian Y, Zhou R, Yang Y et a | Mol Psychiatry | 2026 | 0 |
| The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] | Rosner D, Sun J, Cacace R, Yee A, Wagh C | Neuron | 2026 | 0 |
| Integrative Transcriptomic and Bioinformatics Approaches Combined With Transform [PMID:41524613] | Yan D, Li W, Xing E, Wang P, Zhang Z | FASEB J | 2026 | 0 |
| Integrative bioinformatics and machine learning identify shared molecular mechan [PMID:41961800] | Deng A, Wang W | PLoS One | 2026 | 0 |
| Genome-wide consensus transcriptional signatures identify synaptic pruning linki [PMID:41139712] | Li H, Xie Z, Tian Y, Zhou R, Yang Y, Lin | Molecular psychiatry | 2026 | 0 |
| The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively reg [PMID:41435829] | Rosner D, Sun J, Cacace R, Yee A, Wagh C | Neuron | 2026 | 0 |
| Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. [PMID:20301376] | Adam, Bick, Mirzaa, Pagon, Wallace et al | 1993 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.56 · 2026-04-15
closed · Rounds: 4 · Score: 0.88 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 3 · Score: 0.68 · 2026-04-02
closed · Rounds: 4 · Score: 0.89 · 2026-04-02
closed · Rounds: 4 · Score: 0.57 · 2026-04-01